GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Morepen Laboratories Ltd

Morepen Labs Subsidiary Allots Rs. 20 Cr Equity Shares

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 06 Aug 2026, 05:10 PM IST  ·  BSE ID: ddd4a009-6c9c-49ea-ad0d-4d5c0635eaf2
View Original BSE Filing (PDF)
💡
In Simple Terms
Morepen Labs' subsidiary received Rs. 20 crore in new shares from its parent company to boost its funds.
🤖 AI Summary
  • Morepen RX Limited allotted 2,00,00,000 equity shares of Rs. 10 each to parent Morepen Laboratories.
  • The total consideration for the rights issue allotment amounts to Rs. 20,00,00,000 (Rupees Twenty Crores).
  • This capital infusion is to strengthen Morepen RX Limited's capital base and support its business operations.
  • Morepen RX Limited reported a turnover of Rs. 5,449.84 Lakh and net worth of Rs. 47.72 Lakh for FY26.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Allotted Equity Shares by Morepen RX Limited
2,00,00,000
Face Value per Equity Share
Rs. 10
Total Consideration for Allotment
Rs. 20,00,00,000
Morepen RX Limited Turnover FY26
Rs. 5,449.84 Lakh
Morepen RX Limited Net Worth FY26
Rs. 47.72 Lakh
Morepen Laboratories' Shareholding in MRX (Post Allotment)
2,70,82,356 equity shares
🏢 How This Affects the Company
📈
Business Impact
The subscription strengthens the capital base of Morepen RX Limited, supporting its ongoing pharmaceutical business operations.
💰
Financial Impact
Morepen Laboratories' investment of Rs. 20,00,00,000 increases its stake value in the subsidiary and impacts its cash outflow. Morepen RX Limited's net worth will increase from Rs. 47.72 Lakh.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this allotment.
👤
Who Is Affected
Shareholders are affected as the company's funds are deployed to strengthen a subsidiary's financial position.
🔍
Management Signal
This action signals management's commitment to supporting and growing its subsidiary's business operations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Morepen RX Limited's subsequent financial performance and business growth.
Future capital requirements of the subsidiary.
Consolidated financial results of Morepen Laboratories.
LOW RISK Routine capital infusion into a wholly owned subsidiary.
💡 Investor Takeaway
Morepen Laboratories infused Rs. 20,00,00,000 into its wholly owned subsidiary, Morepen RX Limited, via a rights issue to bolster its capital base and operations.
⚖️ Strengths & Concerns

✅ Positives

  • Subsidiary's capital base strengthened by Rs. 20,00,00,000, enhancing its financial standing.
  • Morepen RX Limited, the subsidiary, reported a turnover of Rs. 5,449.84 Lakh for the financial year ended March 31, 2026.

⚠️ Concerns

  • Morepen RX Limited had a net worth of Rs. 47.72 Lakh as of March 31, 2026, indicating a need for capital infusion.
  • The transaction involves related parties, with promoter group members serving as Directors on the subsidiary's board.
❓ Frequently Asked Questions
What did Morepen RX Limited allot to Morepen Laboratories?
Morepen RX Limited allotted 2,00,00,000 equity shares of Rs. 10 each to Morepen Laboratories.
What is the total value of the equity shares allotted by Morepen RX Limited?
The total value of the equity shares allotted is Rs. 20,00,00,000 (Rupees Twenty Crores).
Why was this allotment made?
The allotment was to strengthen Morepen RX Limited's capital base and support its business operations.
What was Morepen RX Limited's turnover for the financial year ended March 31, 2026?
Morepen RX Limited had a turnover of Rs. 5,449.84 Lakh for the financial year ended March 31, 2026.
What is Morepen Laboratories' current shareholding in Morepen RX Limited?
Post allotment, Morepen Laboratories holds 2,70,82,356 equity shares in Morepen RX Limited.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.